The US FTC conditionally clears the transaction between two neurosurgical companies (Integra / Johnson & Johnson)

What Happened: On February 14, 2017, Integra agreed to purchase Johnson & Johnson’s Codman neurosurgery business (excluding Codman’s neurovascular and drug deliver businesses) for $1.045 billion. Seven months later, on September 25, 2017, the Federal Trade Commission (FTC) agreed to clear the transaction subject to the parties divesting five neurosurgical tools and associated assets including the relevant intellectual property (IP), manufacturing technology and know-how, and research & development (R&D) information related to the five tools. Additionally the

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • United Kingdom’s Competition Authority - CMA (London)
  • McDermott Will & Emery (Washington)

Citation

Louise Aberg, Gregory E. Heltzer, The US FTC conditionally clears the transaction between two neurosurgical companies (Integra / Johnson & Johnson), 25 septembre 2017, e-Competitions September 2017, Art. N° 93068

Visites 40

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues